Clinical trial
Optimizing Pharmacotherapy for Bipolar Alcoholics
NCT00302133 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00302133 |
|---|---|
| Title | Optimizing Pharmacotherapy for Bipolar Alcoholics |
| Official title | Optimizing Pharmacotherapy for Bipolar Alcoholics |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Alcohol Dependence |
| Intervention type | Drug, Other |
| Interventions | Naltrexone hydrochloride, Placebo |
| Enrollment | 88 |
| Start date | May 1, 2006 |
| Primary completion | Apr 1, 2013 |
| Completion | Jul 1, 2013 |
| First posted | Mar 13, 2006 |
| Last update posted | May 17, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: